Thursday, May 19, 2022
  • Hyderabad
  • Telangana
  • Andhra Pradesh
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Reviews
    • Education Today
    • Property
    • Videos
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
Home | India | Zydus Virafin Gets Emergency Use Approval For Treating Moderate Covid 19 Cases

Zydus’ Virafin gets emergency use approval for treating moderate COVID-19 cases

By ANI
Published: Published Date - 04:22 PM, Fri - 23 April 21
This government's approval for use of the antiviral drug comes at a time when India's daily COVID tally is crossing the 3-lakh mark.

New Delhi: The Drugs Controller General of India (DGCI) has approved emergency use for Zydus Cadila’s Pegylated Interferon alpha-2b, ‘Virafin’ for treating moderate COVID-19 infection in adults.

A release by Cadila Health said, “The drug has also shown efficacy against other viral infections.”

Speaking on the development, Dr Sharvil Patel, Managing Director, Cadila Healthcare Limited said: “The fact that we are able to offer a therapy which significantly reduces viral load when given early on can help in better disease management. It comes at a much-needed time for patients and we will continue to provide them access to critical therapies in this battle against COVID-19.”

This government’s approval for use of the antiviral drug comes at a time when India’s daily COVID tally is crossing the 3-lakh mark.

India recorded 3,32,730 new COVID-19 cases in the last 24 hours, the highest single-day spike since the pandemic broke out last year. India has crossed the mark of 3 lakh COVID-19 cases for two consecutive days now.

This has taken the cumulative count of the COVID infection in the country to 1,62,63,695.


Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.

Click to follow Telangana Today Facebook page and Twitter .


  • Follow Us :
  • Tags
  • Covid-19
  • DGCI
  • emergency use approval
  • Virafin

Related News

  • Telangana’s employment rate rebounds post Covid-19

  • India records 2,364 new COVID-19 infections, 10 fatalities

  • India records 2,202 new COVID-19 infections, 27 fatalities

  • JNTU-Hyderabad to revamp curriculum of all its courses

  • Banks need a new playbook

  • India records 2,858 COVID-19 cases, 11 fatalities

Latest News

  • CM KCR embarks on ‘national mission’

    2 hours ago
  • I want to dedicate this victory to all Indians: Telangana’s Nikhat Zareen

    2 hours ago
  • Opinion: Life within Dark Media

    2 hours ago
  • Editorial: Go beyond optics

    2 hours ago
  • Working women face accommodation problem in Hyderabad

    2 hours ago
  • 17.89 lakh acres to be cultivated in erstwhile Warangal

    2 hours ago
  • ‘Credibility’ crisis hits Almas Global

    3 hours ago
  • 15-year-old Hyderabadi encourages students to use old textbooks to save trees

    3 hours ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam